Researchers have developed a novel approach to detect ALS and predict survival by measuring genetic activity in blood cells, a study found.
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder marked by progressive degeneration of upper and lower motor neurons, resulting in paralysis and death typically within 3-5 ...
Additionally, NDC-011, a novel drug combination developed through DR.NOAH's AI-based drug discovery platform, received Orphan Drug Designation (ODD) from the U.S. FDA in 2023 and IND approval for a ...
ALS medication AMX0114 has been well tolerated in early clinical testing, and is now moving to a second, higher-dose trial ...
PRESS RELEASEAB SCIENCE ANNOUNCES NEW PUBLICATION ON MEDRXIV HIGHLIGHTING CLINICAL BENEFIT WITH MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS ...
Using machine learning models, researchers at Michigan Medicine have identified a potential way to diagnose amyotrophic ...
Japan’s Tanabe Pharma, formerly known as Mitsubishi Tanabe and now owned by Bain Capital, has obtained approval from the ...
The news comes eight months after Dane shared in an exclusive statement to PEOPLE that he has been diagnosed with amyotrophic ...
Eric Dane's efforts to raise awareness about amyotrophic lateral sclerosis (ALS) continue with a memoir about his condition.
Amyotrophic lateral sclerosis (ALS) is a progressive, paralytic disorder characterized by degeneration of motor neurons in the brain and spinal cord. It begins insidiously with focal weakness but ...
McCormick played a key role passing Gov. Bill Haslam's Tennessee Promise bill, which offers two-year degrees tuition-free to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback